VISTAGEN THERAPEUTICS, INC. Payments for Restructuring
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Payments for Restructuring of -$9.70 thousand for the 9-month period ending 2014-12-31, per its 10-Q filed 2015-02-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2015-02-17
- VISTAGEN THERAPEUTICS, INC. payments for restructuring for the quarter ending 2014-12-31 was -$4.70K, a 129.56% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. payments for restructuring for the quarter ending 2014-09-30 was -$3.60K.
- VISTAGEN THERAPEUTICS, INC. payments for restructuring for the quarter ending 2014-06-30 was -$1.40K.
- VISTAGEN THERAPEUTICS, INC. payments for restructuring for the quarter ending 2014-03-31 was $100.00.
- VISTAGEN THERAPEUTICS, INC. payments for restructuring for fiscal 2014 was $56.80K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month | Payments for Restructuring 181 month | Payments for Restructuring 184 month |
|---|---|---|---|---|---|---|
| 2014-12-31 | -$4.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-17 | -$8.30K derived: sum of 2 quarters · filed 2015-02-17 | -$9.70K 10-Q · filed 2015-02-17 | -$9.60K derived: sum of 4 quarters · filed 2015-02-17 | ||
| 2014-09-30 | -$3.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-19 | -$5.00K 10-Q · filed 2014-11-19 | -$4.90K derived: sum of 3 quarters · filed 2014-11-19 | $11.00K derived: sum of 4 quarters · filed 2015-02-17 | ||
| 2014-06-30 | -$1.40K 10-Q · filed 2014-08-12 | -$1.30K derived: sum of 2 quarters · filed 2014-08-12 | $14.60K derived: sum of 3 quarters · filed 2015-02-17 | |||
| 2014-03-31 | $100.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-25 | $16.00K derived: sum of 2 quarters · filed 2015-02-17 | $56.80K 10-K · filed 2014-06-25 | $56.80K 10-K · filed 2014-06-25 | ||
| 2013-12-31 | $15.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-17 | $56.70K 10-Q · filed 2015-02-17 | $56.70K 10-Q · filed 2014-02-14 | |||
| 2013-09-30 | $40.80K 10-Q · filed 2014-11-19 | $40.80K 10-Q · filed 2013-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |